Tsubota Laboratory Incorporated (4890) Stock Price & Analysis

4890 Stock Chart & Stats

¥243.00-¥3.00(-1.22%)

At close: Oct 30 3:30 PM GMT+9

Day’s Range: JPY 241.00 - JPY 248.00
52-Week Range: JPY 210.00 - JPY 478.00
Previous Close: JPY 246.00
Volume: 43.10K
Average Volume (3M): 30.84K
Market Cap: JPY 6.31B
Enterprise Value: JPY 5.27B
Total Cash (Recent Filing): JPY 699.26M
Total Debt (Recent Filing): JPY 63.64M
Price to Earnings (P/E): ―
Beta: 0.27
Next Earnings: Nov 11, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

A conservatively financed balance sheet gives Tsubota Laboratory a meaningful cushion while operations fluctuate. Low leverage limits interest and refinancing pressure, preserving financial flexibility to support ophthalmology development and absorb periods of weak earnings.

Strong Gross Margin

The approximately 66% gross margin indicates that the company’s offerings can retain substantial value after direct costs. If revenue stabilizes, this margin profile could provide operating leverage and support a path toward improved profitability despite the current cost burden.

Prior Profitability

Tsubota Laboratory has previously demonstrated the ability to generate operating profit and net income, including a strong 2025 rebound. That record provides evidence that profitability is achievable under better operating conditions, although recent results show that earnings remain highly volatile.

Bears Say

Revenue Collapse

The severe 2026 revenue contraction weakens the scale and visibility of Tsubota Laboratory’s ophthalmology business. A decline of this magnitude can reduce fixed-cost absorption, disrupt the path to sustainable earnings, and make future operating performance highly dependent on recovery.

Deep Operating Losses

Deep losses show that gross profit is currently insufficient to cover the company’s fixed cost base. Continued negative profitability can erode equity returns, constrain investment in commercialization, and make the business more vulnerable if the revenue decline persists.

Persistent Cash Burn

Persistent negative operating and free cash flow indicates that reported operations are consuming rather than generating cash. Ongoing burn increases funding needs and reduces financial flexibility, even though the balance sheet currently carries low leverage and substantial equity.

Tsubota Laboratory Incorporated News

Tsubota Laboratory Narrows Quarterly Loss as Revenue Surges and Eyes Full-Year Profit

Tsubota Laboratory Incorporated ( ($JP:4890) ) has issued an announcement. Tsubota Laboratory reported a sharp increase in first-quarter revenue to ¥215 million, up more than eightfold year on year, while

2M ago4890

Tsubota Lab Emphasizes ‘VISIONary INNOVATION’ in Vision and Brain Health

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Lab Co., an R&D-based venture from Keio University’s School of Medicine, concentrates on medical and healthcare innovations targeting visual

5M ago4890

Tsubota Laboratory Swings to Loss but Projects Sharp Rebound in 2027

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Laboratory reported a sharp downturn in non-consolidated results for the fiscal year ended March 31, 2026, with revenue plunging

5M ago4890

Tsubota Laboratory Swings to Heavy Loss as Revenue Plunges, Forecasts Deep Full-Year Deficit

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Laboratory reported a sharp deterioration in non-consolidated results for the nine months ended December 31, 2025, with revenue plunging

8M ago4890

Tsubota Laboratory’s Interim Financial Results Highlight Sustainable Growth Strategy

Tsubota Laboratory Incorporated ( ($JP:4890) ) has provided an announcement. Tsubota Laboratory Incorporated has announced its interim financial results for the fiscal year ending March 31, 2026, emphasizing its commitment

11M ago4890

Tsubota Laboratory Reports Significant Revenue Decline and Net Loss

Tsubota Laboratory Incorporated ( ($JP:4890) ) has shared an update. Tsubota Laboratory Incorporated reported a significant decline in its financial performance for the six months ending September 30, 2025, with

11M ago4890

Tsubota Laboratory Reports First Quarter Losses Amidst Sales Decline

An update from Tsubota Laboratory Incorporated ( ($JP:4890) ) is now available. Tsubota Laboratory Incorporated reported a decrease in net sales and continuing losses for the first quarter of the

1y ago4890

Tsubota Laboratory Reports Strong Financial Recovery in FY2025

The latest announcement is out from Tsubota Laboratory Incorporated ( ($JP:4890) ). Tsubota Laboratory, Inc. reported significant financial improvement for the fiscal year ended March 31, 2025, with net sales

1y ago4890

Tsubota Laboratory’s Impressive Financial Turnaround in 2024

Tsubota Laboratory Incorporated (JP:4890) has released an update. Tsubota Laboratory, Inc. reports a significant increase in net sales and profitability for the first half of the fiscal year ending March

1y ago4890

4890 FAQ

What was Tsubota Laboratory Incorporated’s price range in the past 12 months?

Tsubota Laboratory Incorporated lowest stock price was ¥210.00 and its highest was ¥478.00 in the past 12 months.

What is Tsubota Laboratory Incorporated’s market cap?

Tsubota Laboratory Incorporated’s market cap is ¥6.31B.

When is Tsubota Laboratory Incorporated’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Tsubota Laboratory Incorporated’s earnings last quarter?

Tsubota Laboratory Incorporated released its earnings results on Aug 12, 2026. The company reported -¥5.2 earnings per share for the quarter.

Is Tsubota Laboratory Incorporated overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Tsubota Laboratory Incorporated pay dividends?

Tsubota Laboratory Incorporated does not currently pay dividends.

What is Tsubota Laboratory Incorporated’s EPS estimate?

Tsubota Laboratory Incorporated’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Tsubota Laboratory Incorporated have?

Tsubota Laboratory Incorporated has 25,969,738 shares outstanding.

What happened to Tsubota Laboratory Incorporated’s price movement after its last earnings report?

Tsubota Laboratory Incorporated reported an EPS of -¥5.2 in its last earnings report. Following the earnings report the stock price went up 2.23%.

Which hedge fund is a major shareholder of Tsubota Laboratory Incorporated?

Currently, no hedge funds are holding shares in JP:4890

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description